CME Group price target raised to $321 from $281 at Barclays
A sizable target increase with further indicated upside is a positive analyst signal, though a target remains an opinion rather than a guarantee.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
A sizable target increase with further indicated upside is a positive analyst signal, though a target remains an opinion rather than a guarantee.
What happened, with direct paths to the underlying reporting
Barclays raised its CME target by $40, about 14%, to $321. The new target is roughly 8.5% above the posted price of $295.79.
Target: $321
Posted price: $295.79
Analyst firm: Barclays
Analyst: Benjamin Budish
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.